OpenAI researcher in talks to launch $2B AI drug discovery startup

OpenAI researcher Miles Wang is reportedly in funding talks to launch a new startup applying AI to drug discovery, targeting a valuation of $2 billion. The talks reflect continued investor interest in applying AI to life sciences research.

Why it matters: Shows another high-profile AI research talent leaving a major lab to found a specialized applied-AI startup.